Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
15-GI-95-NLG (NLG2104): A Phase 1/2 Study of Indoximod in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas
Anthony, Lowell
(PI)
Goel, Gaurav
(Former PI)
Hosein, Peter
(Former PI)
Mathew, Aju
(Former PI)
Markey Cancer Center / Cancer Research Priority Initiative
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
9/21/15
→
9/13/19
Funding
NewLink Genetics:
$47,539.00
View all
View less